Patent · US Active

Compositions relating to anti-IL-21 receptor antibodies

US9309318B2 · kind B2 · utility

1Cited by
5References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 14, 2013
Grant dateApr 12, 2016
Priority date
Expiry dateDec 6, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compositions and methods relating to antigen binding proteins against IL-21 receptor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.